Lux screens offer an effective platform for high throughput screening and give extraordinary insight into possible mode of action and potency of drug candidates
Lux Biotechnology was established in 2001 by Patrick Hickey.
At the time, he was researching for a PhD at the University of Edinburgh's School of Biological Sciences.
Along side that research, Hickey pursued his interest in luminous fungi - research that led to the creation of a company.
The company has won two prestigious national innovation awards - a Smart Scotland award and a Spur award.
Lux biotech develops enabling technologies for drug discovery, toxicity testing and research.
The company has three product ranges that include whole organism screening, scientific reference devices and a range of novel luminescence and fluorescence research reagents.
Scientists at Lux, mostly recruited from the University of Edinburgh, have been the first to develop screens using fungi that express genes isolated from marine organisms making them glow.
Screening is based on the measurement of light signals emitted by living fungal cells.
Lux screens offer an effective platform for high throughput screening and give extraordinary insight into possible mode of action and potency of drug candidates.
